Teva Gets Nod For $420M Price-Fixing Deal With Investors
A Connecticut federal judge granted preliminary approval to a $420 million deal resolving an investor class action accusing Teva Pharmaceuticals of orchestrating an industrywide price-fixing scheme, holding that the agreement is...To view the full article, register now.
Already a subscriber? Click here to view full article